0001127602-18-034170.txt : 20181121 0001127602-18-034170.hdr.sgml : 20181121 20181121160409 ACCESSION NUMBER: 0001127602-18-034170 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181119 FILED AS OF DATE: 20181121 DATE AS OF CHANGE: 20181121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Clark James David CENTRAL INDEX KEY: 0001757584 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-01011 FILM NUMBER: 181198225 MAIL ADDRESS: STREET 1: ONE CVS DRIVE CITY: WOONSOCKET STATE: RI ZIP: 02760 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CVS HEALTH Corp CENTRAL INDEX KEY: 0000064803 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] IRS NUMBER: 050494040 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 BUSINESS PHONE: 4017651500 MAIL ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 FORMER COMPANY: FORMER CONFORMED NAME: CVS CAREMARK CORP DATE OF NAME CHANGE: 20070509 FORMER COMPANY: FORMER CONFORMED NAME: CVS/CAREMARK CORP DATE OF NAME CHANGE: 20070322 FORMER COMPANY: FORMER CONFORMED NAME: CVS CORP DATE OF NAME CHANGE: 19970128 3 1 form3.xml PRIMARY DOCUMENT X0206 3 2018-11-19 0 0000064803 CVS HEALTH Corp CVS 0001757584 Clark James David ONE CVS DRIVE WOONSOCKET RI 02895 1 SVP, Cont & Chief Acct Officer Common Stock 8040.2554 D Common Stock (restricted) 858 D Common Stock (restricted) 537 D Common Stock (restricted) 831 D Common Stock (restricted) 2214 D Common Stock (restricted) 274 D Common Stock (restricted) 2009 D Common Stock (restricted) 1057 D Common Stock (restricted) 790 D Stock Option 45.07 2013-04-02 2019-04-02 Common Stock 1664 D Stock Option 54.53 2014-04-01 2020-04-01 Common Stock 3030 D Stock Option 74.29 2015-04-01 2021-04-01 Common Stock 5350 D Stock Option 102.26 2016-04-01 2022-04-01 Common Stock 6059 D Stock Option 104.82 2017-04-01 2023-04-01 Common Stock 7044 D Stock Option 78.05 2018-04-03 2024-04-03 Common Stock 9050 D Stock Option 62.21 2019-04-01 2025-04-01 Common Stock 7513 D Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 4/1/2020. Consists of Restricted Stock Units (RSUs) awarded pursuant to Issuer's Performance-Based Restricted Stock Unit Plan, a sub-plan under its 2010 Incentive Compensation Plan. Restrictions on remaining RSUs lapse in two equal installments on 2/28/2019 and 2/28/2020. Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 4/1/2019. Consists of Restricted Stock Units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse 2/28/2021. Consists of Restricted Stock Units (RSUs) awarded pursuant to Issuer's Performance-Based Restricted Stock Unit Plan, a sub-plan under its 2010 Incentive Compensation Plan. Restrictions on remaining RSUs lapse 2/28/2019. Consists of Restricted Stock Units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse 4/1/2022. Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 4/3/2021. Consists of Restricted Stock Units awarded pursuant to Issuer's Performance-Based Restricted Stock Unit Plan, a sub-plan under its 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 2/28/2019. Remaining Options became exercisable in four equal annual installments beginning on 4/2/2013. Remaining Options became exercisable in four equal annual installments beginning on 4/1/2014. Remaining Options became exercisable in four equal annual installments beginning on 4/1/2015. Options became exercisable in four equal annual installments beginning on 4/1/2016. Options became exercisable in four equal annual installments beginning on 4/1/2017. Options became exercisable in four equal annual installments beginning on 4/3/2018. Options become exercisable in four equal annual installments, commencing 4/1/2019. /s/ James D. Clark 2018-11-20